MedTrace Logo

Rapid Build of HIV Related Protective Barriers

NCT03852849 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2019-02-25

No results posted yet for this study

Summary

The purpose of the study is to screen the optimal intervention strategies to rapid establish the protective barriers against HIV-infection by maximally decreasing the viremia among HIV- infected patients.

Conditions

  • Viral Suppression of HIV Infection

Interventions

BEHAVIORAL

Personal involved intervention strategies

Medical institutions will provide personal involved intervention strategies for patients which guided by viral load testing monthly until viral load drop below the detection limit.

DRUG

The dosage of 400mg EFV

The dosage of 400mg EFV will be used in the antiviral therapy.

Sponsors & Collaborators

  • Yunnan Center for Disease Control and Prevention

    collaborator OTHER

  • Yunnan AIDS Care Center

    collaborator OTHER

  • National Center for AIDS/STD Control and Prevention, China CDC

    lead OTHER_GOV

Principal Investigators

  • Zhao Yan, PHD · National Center for AIDS/STD Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2020-12-31
Completion
2021-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03852849 on ClinicalTrials.gov